Jaime Guillén

Jaime Guillén

Auto-generated profile, based on publicly available information

Jaime Guillén

Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Elche-Alicante, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
AGAude De Gassart
Aude De Gassart
KLKieu-Suong Le
Kieu-Suong Le
PBPatrick Brune
Patrick Brune
SASophie Agaugué
Sophie Agaugué
JSJennifer Sims
Jennifer Sims
PFPaul Frohna
Paul Frohna
ICT01, a humanized BTN3A mAb, activates Vγ9Vδ2 T cell antitumor immunity and is well tolerated and pharmacodynamically active in patients.

3 December 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JGJaime Guillén
Jaime Guillén
CFCristina Ferrer-Orta
Cristina Ferrer-Orta
MBMònica Buxaderas
Mònica Buxaderas
DPDolores Pérez-Sánchez
Dolores Pérez-Sánchez
MGMARTA GUERRERO-VALERO
MARTA GUERRERO-VALERO
SCSenena Corbalán-García
Senena Corbalán-García
Significance: Vesicle fusion is an important event in neuronal transmission and endocrine cell secretion. A myriad of proteins containing double C2 domains are involved in this complex process; however, how Ca 2+ and the different types of membrane lipids regulate their function is still not well understood. In this work, we provide structural insights to explain the ability of different C2 domains to interact with Ca 2+ and PI(4,5)P 2 and demonstrate the existence of a specific PI(4,5)P 2 -binding motif that provides these domains with specific properties to interact with the membrane and initiate vesicle fusion. We also demonstrate a unique molecular mechanism conferring their specificity for the different phosphoinositides, which resides in additional amino acidic residues surrounding the key interacting lysines.

1 February 2005 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
JGJaime Guillén
Jaime Guillén
APAna J. Pérez-Berná
Ana J. Pérez-Berná
MMMiguel R. Moreno
Miguel R. Moreno
JVJosé Villalaín
José Villalaín
We have identified the membrane-active regions of the severe acute respiratory syndrome coronavirus (SARS CoV) spike glycoprotein by determining the effect on model membrane integrity of a 16/18-mer SARS CoV spike glycoprotein peptide library. By monitoring the effect of this peptide library on membrane leakage in model membranes, we have identified three regions on the SARS CoV spike glycoprotein with membrane-interacting capabilities: region 1, located immediately upstream of heptad repeat 1 (HR1) and suggested to be the fusion peptide; region 2, located between HR1 and HR2, which would be analogous to the loop domain of human immunodeficiency virus type 1; and region 3, which would correspond to the pretransmembrane region. The identification of these membrane-active regions, which are capable of modifying the biophysical properties of phospholipid membranes, supports their direct role in SARS CoV-mediated membrane fusion, as well as facilitating the future development of SARS CoV entry inhibitors.

15 August 2015 in Journal of Virology
Verified
Journal Article
Open access
PDF file
CLChangqing Li
Changqing Li
JGJaime Guillén
Jaime Guillén
NRNadia Rabah
Nadia Rabah
ABAlexandre Blanjoie
Alexandre Blanjoie
FDFrançoise Debart
Françoise Debart
BCBruno Coutard
Bruno Coutard
Alphaviruses are known to possess a unique viral mRNA capping mechanism involving the viral nonstructural protein nsP1. This enzyme harbors methyltransferase (MTase) and nsP1 guanylylation (GT) activities catalyzing the transfer of the methyl group from S -adenosylmethionine (AdoMet) to the N7 position of a GTP molecule followed by the formation of an m 7 GMP-nsP1 adduct. Subsequent transfer of m 7 GMP onto the 5′ end of the viral mRNA has not been demonstrated in vitro yet. Here we report the biochemical characterization of Venezuelan equine encephalitis virus (VEEV) nsP1. We have developed enzymatic assays uncoupling the different reactions steps catalyzed by nsP1. The MTase and GT reaction activities were followed using a nonhydrolyzable GTP (GIDP) substrate and an original Western blot assay using anti-m 3 G/m 7 G-cap monoclonal antibody, respectively. The GT reaction is stimulated by S -adenosyl- l -homocysteine (Ado-Hcy), the product of the preceding MTase reaction, and metallic ions. The covalent linking between nsP1 and m 7 GMP involves a phosphamide bond between the nucleotide and a histidine residue. Final guanylyltransfer onto RNA was observed for the first time with an alphavirus nsP1 using a 5′-diphosphate RNA oligonucleotide whose sequence corresponds to the 5′ end of the viral genome. Alanine scanning mutagenesis of residues H37, H45, D63, E118, Y285, D354, R365, N369, and N375 revealed their respective roles in MT and GT reactions. Finally, the inhibitory effects of sinefungin, aurintricarboxylic acid (ATA), and ribavirin triphosphate on MTase and capping reactions were investigated, providing possible avenues for antiviral research. IMPORTANCE Emergence or reemergence of alphaviruses represents a serious health concern, and the elucidation of their replication mechanisms is a prerequisite for the development of specific inhibitors targeting viral enzymes. In particular, alphaviruses are able, through an original reaction sequence, to add to their mRNA a cap required for their protection against cellular nucleases and initiation of viral proteins translation. In this study, the capping of a 5′ diphosphate synthetic RNA mimicking the 5′ end of an alphavirus mRNA was observed in vitro for the first time. The different steps for this capping are performed by the nonstructural protein 1 (nsP1). Reference compounds known to target the viral capping inhibited nsP1 enzymatic functions, highlighting the value of this enzyme in antiviral development.

25 February 2006 in Biochemistry
Verified
Journal Article
Closed access
APAna J. Pérez-Berná
Ana J. Pérez-Berná
MMMiguel R. Moreno
Miguel R. Moreno
JGJaime Guillén
Jaime Guillén
Angela Bernabeu SanzAngela Bernabeu Sanz
Angela Bernabeu Sanz
JVJosé Villalaín
José Villalaín

1 September 2006 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
LPLaura Pérez-Fons
Laura Pérez-Fons
FAFrancisco J. Aranda
Francisco J. Aranda
JGJaime Guillén
Jaime Guillén
JVJosé Villalaín
José Villalaín
Vicente MicolVicente Micol
Vicente Micol